BridgeMD
New treatment option for Hematologic Malignancy
Official title Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy
ClinicalTrials.gov ID: NCT06689800
What this study is testing
- What it's testing
- The investigators will conduct a pilot feasibility and efficacy trial of a newly developed family health communication tool (called Let's Get REAL) in increasing youth involvement in real-time stem cell transplant and cellular therapy decisions (SCTCT). The investigators will pilot the intervention among 24 youth and their parents, stratified by youth age (stratum 1, 8-12 years of age and stratum 2, 13-17 years of age).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 8 and older
You may be able to join if
- Youth:
- Children or adolescents 8-17 years of age referred for SCTCT.
- Diagnosis of malignant or nonmalignant disorder.
- Referred for any type of SCTCT. Autologous and allogeneic stem cell and cellular therapies are eligible.
- Planning to meet with a provider to discuss SCTCT.
You likely can't join if
- Youth:
- Active medical problems severe enough to preclude study participation at the time of recruitment.
- Patients who are otherwise eligible, but whose primary transplant physician does not want them to participate in the study.
- Lacks cognitive capacity to complete study activities, as determined by consenting professional. Exclusion Criteria Parents:
- Their youth referred for SCTCT does not assent to participate.
See the full eligibility criteria
- Youth:
- Children or adolescents 8-17 years of age referred for SCTCT.
- Diagnosis of malignant or nonmalignant disorder.
- Referred for any type of SCTCT. Autologous and allogeneic stem cell and cellular therapies are eligible.
- Planning to meet with a provider to discuss SCTCT.
- Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed assent document.
- Must speak English and be cognitively able to participate. Parents:
- Parent or guardian of a child 8-17 years of age with any diagnosis referred for any type of SCTCT. Diagnoses may include malignant and nonmalignant disorders. Autologous and allogeneic stem cell and cellular therapies...
- Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed consent document.
- Must speak English and be cognitively able to participate.
- Youth:
- Active medical problems severe enough to preclude study participation at the time of recruitment.
- Patients who are otherwise eligible, but whose primary transplant physician does not want them to participate in the study.
- Lacks cognitive capacity to complete study activities, as determined by consenting professional. Exclusion Criteria Parents:
- Their youth referred for SCTCT does not assent to participate.
The study team makes the final eligibility decision.
Where it's taking place
- St Louis, Missouri, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 8 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include St Louis, Missouri, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.